Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ginkgo biloba + piracetam + vinpocetine
- Development stage
- Unknown
- Lead developer
- Ind Blues Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
**COG 3** is a fixed-dose combination cognitive enhancer developed and marketed by Ind Blues Pharma. It is formulated as an oral tablet containing three active ingredients: ginkgo biloba extract (60 mg), piracetam (800 mg), and vinpocetine (5 mg). This combination is primarily indicated for improving cognitive function, memory, and concentration in patients with neurodegenerative disorders such as dementia, Alzheimer's disease, and Parkinson's disease. Ginkgo biloba acts as an antioxidant and improves cerebral blood flow; piracetam is a nootropic that modulates cholinergic and glutamatergic systems to enhance neuroplasticity; and vinpocetine acts as a vasodilator and phosphodiesterase inhibitor to further enhance cerebral circulation and protect neurons from hypoxia.
- Brand names
- COG 3COG3COG-3Cog 3 TabletCog3 TabletCog-3 Tablet
- Other names
- ginkgo biloba + piracetam + vinpocetineginkgo biloba extract + piracetam + vinpocetine
02
Targets
AcetylcholinesteraseMAOA (Monoamine oxidase A)mAChR (Muscarinic acetylcholine receptors)NMDAR (Glutamate receptor ionotropic, NMDA)PDE1 (Phosphodiesterase 1)PTAFR (Platelet-activating factor receptor)NaV (Voltage-gated sodium channels)NEMO (NF-κB essential modulator)
Beyond the preview
Go deeper on ginkgo biloba + piracetam + vinpocetine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ginkgo biloba + piracetam + vinpocetine.